Skip to main content

$5.19 0.12 (2.37%)

High

$5.29

Low

$5.12

Trades

1,945

Turnover

$3,576,754

Volume

686,116
30 June 2023 at 4:10pm
Register to track AVH and receive email alerts.
Subject
AVH Ann: FDA Approves IDE Amendment to AVITA's Vitiligo Pivotal Study

AVH Ann: AVITA to Announce Fiscal 4th Quarter 2021 Financial Results

AVH Ann: Change in substantial holding

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: Appendix 3G

AVH Ann: Appendix 3G

AVH Ann: Appendix 4A

AVH Ann: Appendix 3H

AVH Ann: Cleansing Notice under s708A(5)(e) of the Corporations Act

AVH Ann: Appendix 3G

AVH Ann: Initial Director's Interest Notice - Jan Stern Reed

AVH Ann: Initial Director's Interest Notice - J. Corbett

AVH Ann: AVITA Medical Announces Inclusion in the Russell 3000 Index

AVH Ann: AVITA Medical Investor Briefing

AVH Ann: AVITA Announces Preliminary Q4 2021 Financial Results

AVH Ann: U.S. FDA Approves Expanded Use of the RECELL System

AVH Ann: Change of Director's Interest Notice - Michael Perry

AVH Ann: Cleansing Notice under s708A(5)(e) of the Corporations Act

AVH Ann: Appendix 3G

AVH Ann: Appendix 4A

AVH Ann: Cleansing Notice under s708A(5)(e) of the Corporations Act

AVH Ann: Appendix 3G

AVH Ann: AVH Appoints Two New Non-Executive Members to the Board

AVH Ann: Appendix 3G

AVH Ann: Avita Medical Reports Third Quarter 2021 Financial Results

AVH Ann: Financial Report for Fiscal Third Quarter 2021 Form 10Q

AVH Ann: Appendix 4A

AVH Ann: Appendix 3G

AVH Ann: AVITA to Announce Fiscal 3rd Quarter 2021 Financial Results

AVH Ann: Appendix 3G

AVH Ann: RECELL Data to be Presented at Boswick Symposium

AVH Ann: Appointment of Jeremy Curnock Cook to Audit Committee

AVH Ann: Appendix 4A

AVH Ann: 15 RECELL Abstracts Accepted at 53rd Annual ABA Meeting

AVH Ann: Change of Director's Interest Notice - Michael Perry

AVH Ann: Appendix 3G

AVH Ann: Appointment of Chief Financial Officer

AVH Ann: Form 10-K/A filed with the SEC

AVH Ann: Appendix 3G

AVH Ann: Appendix 3G

AVH Ann: Appendix 4A

AVH Ann: Appendix 3G

AVH Ann: Cleansing Notice under s708(5)(e) of the Corporations Act

AVH Ann: Closing of Offering of 3,214,250 Shares in Common Stock

AVH Ann: Prospectus Supplement

AVH Ann: Proposed issue of Securities - AVH

AVH Ann: Removal of Trading Halt Request

AVH Ann: Preliminary Prospectus Supplement

AVH Ann: Trading Halt

Register to track AVH and receive email alerts.